Featured Job
-
Job Removed or Not Found
Related Jobs
- Insmed Incorporated (NJ)
- …As a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases, you'll be part of a community that prioritizes the
- Legend Biotech USA, Inc. (Philadelphia, PA)
- …Lead and oversee all toxicology strategy and execution for preclinical development programs in cell and gene therapy.Design, implement, and interpret nonclinical safety
- Legend Biotech USA, Inc. (Raritan, NJ)
- …Manage the global Compliance leads to ensure harmonization and alignment across all functions and sites.Support the development of the GMP Compliance program related to
- Repligen (Waltham, MA)
- …location, internal equity, and alignment with market data. Additionally, employees are eligible to participate in one of our variable cash programs (bonus or commission)
- Eisai, Inc (Cincinnati, OH)
- …Responsible for meeting/exceeding Oncology sales goals for an assigned territory by promoting Oncology therapeutic products in a compliant and appropriate
- Eisai, Inc (Indianapolis, IN)
- …Act as the point of contact for assigned customers with patient access and reimbursement needs/challenges to provide relevant education and support.Identify, triage, and
- Merck & Co. (Upper Gwynedd, PA)
- …Specifically, the Senior Director may be responsible for: -Analyzing and summarizing the clinical findings from studies to support decisions regarding safety and efficacy
- Novo Nordisk Inc. (Plainsboro, NJ)
- …A Bachelor's degree in Business or equivalent experience. MBA, PharmD, or another advanced degree preferred A minimum of twelve (12) years of experience in market access
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …Reporting to the Sr. Director, Medical Affairs QA, the Director of Medical Affairs QA is responsible for providing strategic leadership and comprehensive quality
- Formation Bio (New York, NY)
- …Develop and execute IP strategies that maximize asset value from in-licensing through exit Lead IP due diligence for pharmaceutical and biologic acquisitions, identifying